BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15110316)

  • 41. Biochemical basis of the beta-glucuronidase gene defect causing canine mucopolysaccharidosis VII.
    Ray J; Scarpino V; Laing C; Haskins ME
    J Hered; 1999; 90(1):119-23. PubMed ID: 9987917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enzyme replacement therapy for murine mucopolysaccharidosis type VII.
    Sands MS; Vogler C; Kyle JW; Grubb JH; Levy B; Galvin N; Sly WS; Birkenmeier EH
    J Clin Invest; 1994 Jun; 93(6):2324-31. PubMed ID: 8200966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
    Zhu J; Kang W; Wolfe JH; Fraser NW
    Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ultrastructural analysis of different skeletal cell types in mucopolysaccharidosis dogs at the onset of postnatal growth.
    Jiang Z; Lau YK; Wu M; Casal ML; Smith LJ
    J Anat; 2021 Feb; 238(2):416-425. PubMed ID: 32895948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of beta-glucuronidase.
    Taylor RM; Wolfe JH
    Nat Med; 1997 Jul; 3(7):771-4. PubMed ID: 9212105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term normalization in the central nervous system, ocular manifestations, and skeletal deformities by a single systemic adenovirus injection into neonatal mice with mucopolysaccharidosis VII.
    Kamata Y; Tanabe A; Kanaji A; Kosuga M; Fukuhara Y; Li XK; Suzuki S; Yamada M; Azuma N; Okuyama T
    Gene Ther; 2003 Mar; 10(5):406-14. PubMed ID: 12601395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival.
    Vogler C; Sands MS; Levy B; Galvin N; Birkenmeier EH; Sly WS
    Pediatr Res; 1996 Jun; 39(6):1050-4. PubMed ID: 8725268
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accumulation of abnormal amounts of glycosaminoglycans in murine mucopolysaccharidosis type VII neural progenitor cells does not alter the growth rate or efficiency of differentiation into neurons.
    Heuer GG; Skorupa AF; Prasad Alur RK; Jiang K; Wolfe JH
    Mol Cell Neurosci; 2001 Jan; 17(1):167-78. PubMed ID: 11161477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease.
    Hofling AA; Devine S; Vogler C; Sands MS
    Mol Ther; 2004 Jun; 9(6):856-65. PubMed ID: 15194052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrathecal AAVrh10 corrects biochemical and histological hallmarks of mucopolysaccharidosis VII mice and improves behavior and survival.
    Pagès G; Giménez-Llort L; García-Lareu B; Ariza L; Navarro M; Casas C; Chillón M; Bosch A
    Hum Mol Genet; 2019 Nov; 28(21):3610-3624. PubMed ID: 31511867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravitreal gene therapy reduces lysosomal storage in specific areas of the CNS in mucopolysaccharidosis VII mice.
    Hennig AK; Levy B; Ogilvie JM; Vogler CA; Galvin N; Bassnett S; Sands MS
    J Neurosci; 2003 Apr; 23(8):3302-7. PubMed ID: 12716937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delayed hypertrophic differentiation of epiphyseal chondrocytes contributes to failed secondary ossification in mucopolysaccharidosis VII dogs.
    Peck SH; O'Donnell PJ; Kang JL; Malhotra NR; Dodge GR; Pacifici M; Shore EM; Haskins ME; Smith LJ
    Mol Genet Metab; 2015 Nov; 116(3):195-203. PubMed ID: 26422116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Encapsulation cell therapy for mucopolysaccharidosis type VII using genetically engineered immortalized human amniotic epithelial cells.
    Nakama H; Ohsugi K; Otsuki T; Date I; Kosuga M; Okuyama T; Sakuragawa N
    Tohoku J Exp Med; 2006 May; 209(1):23-32. PubMed ID: 16636519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Engraftment of genetically engineered amniotic epithelial cells corrects lysosomal storage in multiple areas of the brain in mucopolysaccharidosis type VII mice.
    Kosuga M; Sasaki K; Tanabe A; Li XK; Okawa H; Ogino I; Okuda O; Arai H; Sakuragawa N; Kamata Y; Azuma N; Suzuki S; Yamada M; Okuyama T
    Mol Ther; 2001 Feb; 3(2):139-48. PubMed ID: 11237670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus.
    Watson GL; Sayles JN; Chen C; Elliger SS; Elliger CA; Raju NR; Kurtzman GJ; Podsakoff GM
    Gene Ther; 1998 Dec; 5(12):1642-9. PubMed ID: 10023443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.
    Stein CS; Kang Y; Sauter SL; Townsend K; Staber P; Derksen TA; Martins I; Qian J; Davidson BL; McCray PB
    Mol Ther; 2001 Jun; 3(6):850-6. PubMed ID: 11407898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Self-complementary AAV vector therapy for treating corneal cloudiness of mucopolysaccharidosis type VII (MPS VII).
    Venkatakrishnan J; Yuan Y; Zhang J; Yu Y; Hu YC; Kao WW
    Ocul Surf; 2024 Apr; 32():39-47. PubMed ID: 38218582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain.
    Cubizolle A; Serratrice N; Skander N; Colle MA; Ibanes S; Gennetier A; Bayo-Puxan N; Mazouni K; Mennechet F; Joussemet B; Cherel Y; Lajat Y; Vite C; Bernex F; Kalatzis V; Haskins ME; Kremer EJ
    Mol Ther; 2014 Apr; 22(4):762-73. PubMed ID: 24343103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reversal of established bone pathology in MPS VII mice following lentiviral-mediated gene therapy.
    Derrick-Roberts AL; Panir K; Pyragius CE; Zarrinkalam KH; Atkins GJ; Byers S
    Mol Genet Metab; 2016 Nov; 119(3):249-257. PubMed ID: 27692945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function.
    O'Connor LH; Erway LC; Vogler CA; Sly WS; Nicholes A; Grubb J; Holmberg SW; Levy B; Sands MS
    J Clin Invest; 1998 Apr; 101(7):1394-400. PubMed ID: 9525982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.